Details

Immunology


Immunology

Mucosal and Body Surface Defences
1. Aufl.

von: Andrew E. Williams

44,99 €

Verlag: Wiley
Format: PDF
Veröffentl.: 13.09.2011
ISBN/EAN: 9780470090053
Sprache: englisch
Anzahl Seiten: 472

DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.

Beschreibungen

<b>2012 PROSE Award, Clinical Medicine: Honorable Mention</b><br /><br />The vast majority of medically important pathogens infect their host across a body surface such as the skin, or across a mucosal tissue such as the respiratory tract or intestines, as these sites are the ones exposed to the external environment. By focusing on immunity at mucosal and body surfaces this book presents a fresh, new approach to the teaching of immunology. <p>After an introduction to the basic structure of the immune system, the book looks at two important families of signalling molecules: cytokines and chemokines, before covering the workings of the mucosal immune system. It continues by examining immunity against the four major groups of pathogens - viruses, bacteria, fungi and parasites, and concludes by looking at disorders of the immune system, mucosal tumour immunology and the process of vaccination.</p> <ul> <li>A fresh, new approach to the subject focusing on mucosal and body surfaces.</li> <li>Describes the mucosal immune systems of the gastrointestinal, respiratory and urogenital tracts, as well as the skin.</li> <li>Details the important roles of cytokines and chemokines in an immune response.</li> <li>Separate chapters devoted to immunity against viruses, bacteria, fungi and parasites.</li> <li>Includes chapter summaries, boxes with topics of special interest and an extensive glossary.</li> <li>Clearly written and well- illustrated in full colour throughout.</li> </ul> <p>Students across a range of disciplines, including biology, biochemistry, biomedicine, medicine and veterinary sciences, will find this book invaluable, both as an introduction to basic immunology and as a guide to mucosal immune defence mechanisms.</p>
<b>Preface, xv</b> <p><b>List of Standard Cells and Symbols, xvii</b></p> <p><b>1 Basic Concepts in Immunology, 1</b></p> <p>1.1 The immune system, 1</p> <p>1.2 Tissues and cells of the immune system, 1</p> <p>1.3 Activation, regulation and functions of immune responses, 4</p> <p>1.4 Innate versus adaptive immunity, 5</p> <p>1.5 Primary and secondary immune responses, 6</p> <p>1.6 Immune cell development, 7</p> <p>1.7 Mast cells and basophils, 9</p> <p>1.8 Eosinophils, 11</p> <p>1.9 Neutrophils, 11</p> <p>1.10 Monocytes and macrophages, 11</p> <p>1.11 Dendritic cells, 12</p> <p>1.12 Natural killer cells, 12</p> <p>1.13 CD4+ T helper cells, 13</p> <p>1.14 CD8+ cytotoxic T cells, 14</p> <p>1.15 B cells, 15</p> <p>1.16 γδ T cells, 16</p> <p>1.17 Natural killer T cells, 16</p> <p>1.18 Anatomy of the immune system, 16</p> <p>1.19 Lymph nodes, 16</p> <p>1.20 Spleen, 19</p> <p>1.21 Summary, 19</p> <p><b>2 The Innate Immune System, 20</b></p> <p>2.1 Introduction to the innate immune system, 20</p> <p>2.2 Innate immune receptors and cells, 20</p> <p>2.3 TLRs and pattern recognition, 22</p> <p>2.4 TLR signalling in response to LPS, 23</p> <p>2.5 Peptidoglycan and Nods, 24</p> <p>2.6 Nod-like receptors recognize PAMPs and DAMPs, 25</p> <p>2.7 Damage associated molecular patterns (DAMPs), 26</p> <p>2.8 Complement proteins perform several innate immune functions, 27</p> <p>2.9 The classical complement pathway, 28</p> <p>2.10 The lectin and alternative complement pathways, 29</p> <p>2.11 Biological properties of complement cleavage products, 29</p> <p>2.12 Opsonization by complement proteins, 30</p> <p>2.13 Phagocytosis, 31</p> <p>2.14 Fc receptors induce phagocytosis, 32</p> <p>2.15 Neutrophil function and the respiratory burst, 32</p> <p>2.16 ADCC, 33</p> <p>2.17 NK cells recognize missing self, 35</p> <p>2.18 Activating adaptive immunity, 36</p> <p>2.19 Dendritic cells link innate and adaptive immunity, 38</p> <p>2.20 Summary, 40</p> <p><b>3 The Adaptive Immune System, 41</b></p> <p>3.1 Introduction to adaptive immunity, 41</p> <p>3.2 T cells and B cells recognize foreign antigens, 41</p> <p>3.3 Overview of antibody structure, 42</p> <p>3.4 Constant region and antibody isotypes, 45</p> <p>3.5 B cell receptor (BCR) diversity, 46</p> <p>3.6 Genetic recombination of BCR genes, 46</p> <p>3.7 Mechanism of VDJ recombination, 47</p> <p>3.8 Introducing junctional diversity, 48</p> <p>3.9 Somatic hypermutation and affinity maturation, 49</p> <p>3.10 Immunoglobulin class switching, 50</p> <p>3.11 Structure of Fc receptors, 51</p> <p>3.12 Fc receptor specificity and affinity, 53</p> <p>3.13 Cross-linking of antibody is necessary for Fc receptor signalling, 53</p> <p>3.14 Fc receptor immune functions, 54</p> <p>3.15 T cell receptor diversification, 54</p> <p>3.16 T cells undergo positive and negative selection within the thymus, 55</p> <p>3.17 Antigen presentation to T cells, 57</p> <p>3.18 MHC class II processing pathway, 59</p> <p>3.19 MHC class I processing pathway, 59</p> <p>3.20 Activation requires co-stimulation, 60</p> <p>3.21 Late co-stimulatory signals, 62</p> <p>3.22 Activation of B cell responses, 63</p> <p>3.23 CD4+ T helper cell differentiation, 63</p> <p>3.24 Activation of CTLs, 65</p> <p>3.25 Generation of memory T cells, 66</p> <p>3.26 Summary, 67</p> <p><b>4 Cytokines, 68</b></p> <p>4.1 Introduction to cytokines, 68</p> <p>4.2 Structure of cytokine families, 69</p> <p>4.3 IL-1 superfamily, 71</p> <p>4.4 IL-6 family, 71</p> <p>4.5 IL-10 family, 72</p> <p>4.6 Common γ-chain family, 73</p> <p>4.7 IL-12 family, 74</p> <p>4.8 Interferons, 75</p> <p>4.9 TNF ligand superfamily, 75</p> <p>4.10 Growth factors, 77</p> <p>4.11 Functional classification Th1 versus Th2, 78</p> <p>4.12 Th17, immunopathology and regulatory cytokines, 79</p> <p>4.13 Cytokine receptor signalling, 79</p> <p>4.14 Type I and type II cytokine receptors, 79</p> <p>4.15 The JAK/STAT signalling pathway, 80</p> <p>4.16 IL-2 signalling through the JAK/STAT pathway, 81</p> <p>4.17 The JAK/STAT pathway is also used by IL-6, 83</p> <p>4.18 Plasticity in type I cytokine signalling, 83</p> <p>4.19 Suppressor of cytokine signalling (SOCS), 83</p> <p>4.20 IFN-γ signalling pathway, 84</p> <p>4.21 TGF-β and the SMAD signalling pathway, 85</p> <p>4.22 Type III cytokine receptors and the TNF receptor family, 86</p> <p>4.23 The IKK complex and the activation of NF-κB, 87</p> <p>4.24 The IL-1R family of type IV cytokine receptors activate NF-κB, 88</p> <p>4.25 Soluble cytokine receptors act as decoy receptors, 90</p> <p>4.26 IL-33 and ST2 signal regulation, 91</p> <p>4.27 Potential for cytokine therapy, 91</p> <p>4.28 Summary, 92</p> <p><b>5 Chemokines, 93</b></p> <p>5.1 Introduction, 93</p> <p>5.2 Structure and nomenclature of chemokines, 93</p> <p>5.3 Chemokine receptors, 94</p> <p>5.4 Expression of chemokines and their receptors, 97</p> <p>5.5 Chemokines promote extravasation of leukocytes, 97</p> <p>5.6 Chemotaxis, 99</p> <p>5.7 Chemokine receptor signalling cascade, 99</p> <p>5.8 Tissue specific homing, 100</p> <p>5.9 Lymphocyte migration to secondary lymphoid tissues, 101</p> <p>5.10 Chemokines involved in lymphoid structure formation, 102</p> <p>5.11 Chemokines contribute to homeostasis, 104</p> <p>5.12 Chemokine receptors on T cell subsets, 104</p> <p>5.13 Redundancy in the chemokine/receptor system, 106</p> <p>5.14 Chemokines in disease, 108</p> <p>5.15 Chemokines as new anti-inflammatory drugs, 109</p> <p>5.16 Summary, 110</p> <p><b>6 Basic Concepts in Mucosal Immunology, 111</b></p> <p>6.1 Introduction, 111</p> <p>6.2 What is a mucosal tissue?, 112</p> <p>6.3 Immune defence at mucosal tissue is multi-layered, 113</p> <p>6.4 Origins of mucosal associated lymphoid tissue, 114</p> <p>6.5 Concept of the common mucosal immune system, 115</p> <p>6.6 How do T and B lymphocytes migrate into mucosal tissues?, 116</p> <p>6.7 Special features of mucosal epithelium, 117</p> <p>6.8 Toll-like receptors and NOD proteins in the mucosa, 120</p> <p>6.9 Antigen sampling at mucosal surfaces, 121</p> <p>6.10 Mucosal dendritic cells, 122</p> <p>6.11 Secretory dimeric IgA at mucosal surfaces, 124</p> <p>6.12 Regulation of J-chain and secretory component expression, 126</p> <p>6.13 How does the sub-mucosa differ from the epithelium?, 126</p> <p>6.14 Organized lymphoid tissue of the mucosa, 127</p> <p>6.15 Cytokines in the mucosa, 128</p> <p>6.16 Pathogens that enter via mucosal sites, 130</p> <p>6.17 Immune diseases of mucosal tissues, 130</p> <p>6.18 Summary, 132</p> <p><b>7 Immunology of the Gastrointestinal Tract, 133</b></p> <p>7.1 Structure of the gastrointestinal tract, 133</p> <p>7.2 Development of the gastrointestinal tract, 133</p> <p>7.3 The digestive tract as a mucosal tissue, 135</p> <p>7.4 Barrier function, 136</p> <p>7.5 Defensins and Trefoil factors, 138</p> <p>7.6 Structure of Peyer’s patches, 139</p> <p>7.7 Lymphoid follicles and germinal centre formation, 140</p> <p>7.8 M cells sample the intestinal lumen, 143</p> <p>7.9 Dendritic cells sample the lumen contents, 143</p> <p>7.10 Lymphocytes within the epithelium (IELs), 143</p> <p>7.11 γδ T cells in the GALT, 146</p> <p>7.12 NKT cells, 147</p> <p>7.13 T cells in the lamina propria, 148</p> <p>7.14 Maintenance of T cell homeostasis, 148</p> <p>7.15 Sub-mucosal B cells and mucosal IgA, 149</p> <p>7.16 How IgA is produced at intestinal mucosal sites, 150</p> <p>7.17 Cytokines in the gut, 151</p> <p>7.18 Chemokines and the homing of lymphocytes to GALT, 152</p> <p>7.19 Pathogens and immune diseases, 153</p> <p>7.20 Summary, 154</p> <p><b>8 Immunology of the Airways, 156</b></p> <p>8.1 The airways as a mucosal tissue, 156</p> <p>8.2 Development of the respiratory tract, 156</p> <p>8.3 The structure of the respiratory tract, 158</p> <p>8.4 Barrier function and the mucociliary elevator, 159</p> <p>8.5 Mucins and mucociliary clearance, 160</p> <p>8.6 Defensins and antimicrobial peptides, 160</p> <p>8.7 Structure of the tonsils and adenoids of the Waldeyer’s Ring, 161</p> <p>8.8 Local lymph nodes and immune generation, 163</p> <p>8.9 Structure of the NALT, 165</p> <p>8.10 Structure of the BALT, 165</p> <p>8.11 Cells of the lower respiratory tract, 166</p> <p>8.12 Surfactant proteins, 167</p> <p>8.13 Immune modulation by airway epithelial cells, 167</p> <p>8.14 Innate immune response, 168</p> <p>8.15 Dendritic cells are located throughout the respiratory tract, 168</p> <p>8.16 Alveolar macrophages maintain homeostasis, 169</p> <p>8.17 NK cells in the lung, 171</p> <p>8.18 T cells at effector sites in the lung, 171</p> <p>8.19 Memory T cell responses within the lung, 172</p> <p>8.20 Migration of circulating T cell into the lung tissue, 172</p> <p>8.21 IgA production in the respiratory tract, 173</p> <p>8.22 Respiratory diseases and pathogens, 174</p> <p>8.23 Summary, 176</p> <p><b>9 Immunology of the Urogenital Tract and Conjunctiva, 177</b></p> <p>9.1 The urogenital tract as a MALT, 177</p> <p>9.2 Epithelial barrier function, 178</p> <p>9.3 Passive immunity, 181</p> <p>9.4 Immunoglobulins, 181</p> <p>9.5 APCs in genital tract mucosa, 182</p> <p>9.6 NK cells and the semi-allogeneic foetus, 183</p> <p>9.7 Pre-eclampsia is an immune-mediated disease, 184</p> <p>9.8 Maintenance of foetal tolerance, 185</p> <p>9.9 T cells and adaptive immunity, 186</p> <p>9.10 Sexually transmitted diseases and pelvic inflammatory disease, 187</p> <p>9.11 Alloimmunization and autoimmune diseases, 189</p> <p>9.12 The foetal and neonatal immune system, 189</p> <p>9.13 Immunity in the urinary tract, 190</p> <p>9.14 Eye associated lymphoid tissue, 191</p> <p>9.15 Conjunctiva associated lymphoid tissue (CALT), 192</p> <p>9.16 Immune privilege of the eye, 192</p> <p>9.17 Immune privilege and inflammation, 193</p> <p>9.18 Conjunctivitis, 194</p> <p>9.19 Summary, 195</p> <p><b>10 Immunology of the Skin, 196</b></p> <p>10.1 The skin as an immune tissue, 196</p> <p>10.2 Barrier Immune function of the skin, 196</p> <p>10.3 Cellular immune system of the skin, 198</p> <p>10.4 Keratinocytes can act as immune cells, 199</p> <p>10.5 Keratinocytes secrete antimicrobial peptides, 200</p> <p>10.6 Langerhan’s cells act as immune sentinels in skin, 202</p> <p>10.7 Dermal dendritic cells and cross-presentation of antigen, 203</p> <p>10.8 Mast cells and NK cells in the skin, 205</p> <p>10.9 Intraepidermal lymphocytes in the skin, 206</p> <p>10.10 Lymphocytes in the dermis, 206</p> <p>10.11 Skin homing T cells express CLA, 206</p> <p>10.12 Chemokines and migration, 207</p> <p>10.13 Initiation of an immune response in the skin, 208</p> <p>10.14 Cytokines, 211</p> <p>10.15 Psoriasis, inflammation and autoreactive T cells, 211</p> <p>10.16 Autoimmune-mediated diseases of the skin, 213</p> <p>10.17 Systemic diseases that affect the skin, 214</p> <p>10.18 Infectious diseases of the skin, 215</p> <p>10.19 Summary, 216</p> <p><b>11 Immunity to Viruses, 217</b></p> <p>11.1 Introduction, 217</p> <p>11.2 Structure of viruses, 217</p> <p>11.3 Classification of viruses, 218</p> <p>11.4 Viruses replicate within host cells, 218</p> <p>11.5 Infections caused by viruses, 219</p> <p>11.6 Certain viruses can infect immune cells, 220</p> <p>11.7 Virus infection of epithelial cells, 221</p> <p>11.8 IFN-α response, 222</p> <p>11.9 NK cell response to viruses, 222</p> <p>11.10 Viral evasion of NK cell responses, 223</p> <p>11.11 Macrophages contribute to virus elimination, 225</p> <p>11.12 TLRs and NLRs recognize virus motifs, 226</p> <p>11.13 Activation of the inflammasome by viruses, 226</p> <p>11.14 Dendritic cells present virus antigens to CD8+ CTLs, 227</p> <p>11.15 T cell responses to viruses, 229</p> <p>11.16 Evasion of CTL-mediated immunity by viruses, 229</p> <p>11.17 Bystander effects of immune responses to viruses, 231</p> <p>11.18 Antibody response to viruses, 232</p> <p>11.19 Difference between cytopathic and non-cytopathic viruses, 233</p> <p>11.20 Immune evasion by antigenic shift and drift, 235</p> <p>11.21 Vaccination and therapies against viral infections, 235</p> <p>11.22 Summary, 237</p> <p><b>12 Immunity to Bacteria, 238</b></p> <p>12.1 Introduction to bacterial immunity, 238</p> <p>12.2 Classification of bacteria, 238</p> <p>12.3 Structure of the bacterial cell, 240</p> <p>12.4 Diseases caused by bacteria, 241</p> <p>12.5 Mucosal barriers to bacterial infection, 241</p> <p>12.6 Anti-microbial molecules, 242</p> <p>12.7 Recognition of bacterial PAMPs by Toll-like receptors, 243</p> <p>12.8 Complement and bacterial immunity, 244</p> <p>12.9 Neutrophils are central to bacterial immune responses, 245</p> <p>12.10 Some bacteria are resistant to phagosome mediated killing, 247</p> <p>12.11 NK cells and ADCC, 248</p> <p>12.12 The role of antibody in bacterial immunity, 249</p> <p>12.13 Dendritic cells and immunity to bacteria, 250</p> <p>12.14 Autophagy and intracellular bacteria, 251</p> <p>12.15 T Cells contribute to protective immunity, 253</p> <p>12.16 The DTH response and granuloma in TB, 253</p> <p>12.17 Th17 cells in bacterial immunity, 254</p> <p>12.18 Treg cells in bacterial infection, 255</p> <p>12.19 Unconventional T cells, 256</p> <p>12.20 Vaccination against bacterial diseases, 256</p> <p>12.21 Summary, 256</p> <p><b>13 Immunity to Fungi, 258</b></p> <p>13.1 Introduction, 258</p> <p>13.2 Morphology of fungi, 258</p> <p>13.3 Yeasts, 260</p> <p>13.4 Moulds, 260</p> <p>13.5 Fungal dimorphism, 261</p> <p>13.6 Diseases caused by fungi, 262</p> <p>13.7 Immune response to fungi, 263</p> <p>13.8 Innate immunity, 263</p> <p>13.9 Mucosal barriers to fungal infection, 263</p> <p>13.10 Anti-fungal molecules, 265</p> <p>13.11 Recognition of fungal PAMPs by Toll-like receptors, 266</p> <p>13.12 Complement and fungal immunity, 266</p> <p>13.13 Dendritic cells link innate and adaptive fungal immunity, 268</p> <p>13.14 DCs provide the adaptive immune response with instructive signals, 270</p> <p>13.15 Macrophages are important APCs during fungal infection, 270</p> <p>13.16 Neutrophils participate in the inflammatory response to fungi, 271</p> <p>13.17 NK cells provide inflammatory signals to macrophages, 271</p> <p>13.18 Adaptive immunity to fungi, 272</p> <p>13.19 The DTH response and granuloma formation inhibit fungal</p> <p>dissemination, 272</p> <p>13.20 The role of antibody in fungal resistance, 273</p> <p>13.21 Vaccination and immunotherapies, 274</p> <p>13.22 Fungal immune evasion strategies, 276</p> <p>13.23 Immuno-modulatory fungal products, 276</p> <p>13.24 Evasion of phagolysosomal killing, 276</p> <p>13.25 Modifying the cytokine response, 277</p> <p>13.26 Summary, 277</p> <p><b>14 Immunity to Parasites, 278</b></p> <p>14.1 Introduction, 278</p> <p>14.2 Protozoa are diverse unicellular eukaryotes, 278</p> <p>14.3 Structure of the protozoan cell, 278</p> <p>14.4 Life cycle of protozoan parasites, 280</p> <p>14.5 The life cycle of <i>Trypanosoma brucei</i>, 281</p> <p>14.6 Life cycle of <i>Leishmania species</i>, 281</p> <p>14.7 The life cycle of <i>Plasmodium falciparum</i>, 281</p> <p>14.8 Helminths are multicellular, macroscopic parasites, 282</p> <p>14.9 Structure of the trematode <i>Schistosoma mansoni</i>, 283</p> <p>14.10 Life cycle of <i>Schistosoma mansoni</i>, 284</p> <p>14.11 Structure of the nematode <i>Ascaris lumbricoides</i>, 285</p> <p>14.12 The life cycle of <i>A. lumbricoides</i>, 286</p> <p>14.13 Immune responses to parasites, 286</p> <p>14.14 Innate immunity to trypanosomes, 287</p> <p>14.15 Adaptive immunity to trypanosomes, 287</p> <p>14.16 Innate immunity to plasmodium, 288</p> <p>14.17 Adaptive immunity to plasmodium, 289</p> <p>14.18 Immunity to <i>Leishmania</i> – Th1 versus Th2, 290</p> <p>14.19 Immunity to Giardia, 291</p> <p>14.20 Immunity to schistosomes, 292</p> <p>14.21 Innate immunity to schistosomes, 292</p> <p>14.22 Adaptive immunity to schistosomes, 293</p> <p>14.23 Granuloma formation in schistosomiasis, 294</p> <p>14.24 Immunity to intestinal nematode worms, 294</p> <p>14.25 Innate immunity to nematode worms in the gut, 294</p> <p>14.26 Adaptive immunity to nematode worms in the gut, 295</p> <p>14.27 Immune evasion strategies of parasites, 296</p> <p>14.28 Trypanosome variant surface glycoproteins (VSGs), 297</p> <p>14.29 Plasmodium life cycle contributes to immune evasion, 298</p> <p>14.30 <i>Leishmania</i> evade phagocytic killing, 298</p> <p>14.31 Immune evasion strategies of helminths, 298</p> <p>14.32 Summary, 300</p> <p><b>15 Disorders of the Immune System, 302</b></p> <p>15.1 Introduction to immune disorders, 302</p> <p>15.2 Types of allergy, 302</p> <p>15.3 Sensitization and the acute phase response, 304</p> <p>15.4 Mast cell degranulation, 305</p> <p>15.5 Late phase response, 306</p> <p>15.6 Allergic asthma, 307</p> <p>15.7 Mast cells and the early phase allergic asthma, 308</p> <p>15.8 Epithelial cells can trigger allergic asthma, 308</p> <p>15.9 T cells and the late phase of allergic asthma, 310</p> <p>15.10 Allergic rhinitis, 310</p> <p>15.11 Skin allergy and atopic dermatitis, 311</p> <p>15.12 Food allergies, 311</p> <p>15.13 T cell subsets in allergy, 312</p> <p>15.14 Mechanisms of autoimmune disease, 313</p> <p>15.15 Disregulation of tolerance and autoimmunity, 313</p> <p>15.16 Inflammatory bowel disease, 316</p> <p>15.17 Coeliac disease, 317</p> <p>15.18 Systemic lupus erythematosus, 317</p> <p>15.19 Other autoimmune diseases, 318</p> <p>15.20 Immunodeficiencies, 320</p> <p>15.21 Summary, 321</p> <p><b>16 Mucosal Tumour Immunology, 322</b></p> <p>16.1 Introduction, 322</p> <p>16.2 Transformation into cancer cells, 322</p> <p>16.3 Proto-oncogene activation, 323</p> <p>16.4 Mutation in the p53 protein, 324</p> <p>16.5 Mutant Ras proteins enhance proliferation, 324</p> <p>16.6 Aneuploidy and colorectal cancer, 324</p> <p>16.7 Tumourigenesis, 324</p> <p>16.8 Angiogenesis, 326</p> <p>16.9 Metastasis, 327</p> <p>16.10 The immune system and cancer, 327</p> <p>16.11 Immune surveillance, 328</p> <p>16.12 Immunogenicity of tumour cells, 329</p> <p>16.13 Recognition of transformed cells, 330</p> <p>16.14 Tumour associated antigens, 331</p> <p>16.15 Carcinoembryonic antigen in colorectal cancer, 331</p> <p>16.16 Melanoma differentiation antigens, 332</p> <p>16.17 Viral tumour associated antigens, 332</p> <p>16.18 Effector molecules during tumour immune surveillance, 333</p> <p>16.19 Dendritic cells modulate anti-tumour immune responses, 333</p> <p>16.20 Tumour reactive T cells are activated in lymph nodes, 335</p> <p>16.21 NK cell recognition – missing self, 335</p> <p>16.22 NKG2D receptor on NK cells, 335</p> <p>16.23 Macrophages and neutrophils phagocytose tumour cells but support tumour growth, 336</p> <p>16.24 Immune cells can augment tumour growth, 337</p> <p>16.25 Immune evasion strategies, 337</p> <p>16.26 Darwinian selection and tumour cell escape, 338</p> <p>16.27 Cytokine environment and tumour escape, 339</p> <p>16.28 Tumours have disregulated MHC expression and antigen presentation, 339</p> <p>16.29 Tumour escape through Fas/FasL, 340</p> <p>16.30 Summary, 341</p> <p><b>17 Vaccination, 342</b></p> <p>17.1 Introduction, 342</p> <p>17.2 The principles of vaccination, 342</p> <p>17.3 Passive immunization, 344</p> <p>17.4 Active immunization, 344</p> <p>17.5 Processing of the vaccine for immune recognition, 344</p> <p>17.6 Adaptive Immune response following vaccination, 347</p> <p>17.7 Vaccine adjuvants, 347</p> <p>17.8 Alum, 348</p> <p>17.9 Freund’s complete adjuvant, 348</p> <p>17.10 Mucosal adjuvants and vaccine delivery, 350</p> <p>17.11 Prospects in adjuvant design, 350</p> <p>17.12 Th1/Th2 polarization and vaccine development, 351</p> <p>17.13 Live-attenuated vaccines, 351</p> <p>17.14 Inactivated vaccines, 353</p> <p>17.15 Polysaccharide vaccines, 354</p> <p>17.16 Peptide vaccines, 354</p> <p>17.17 DNA vaccination, 355</p> <p>17.18 Immuno-stimulatory complexes (ISCOMs), 355</p> <p>17.19 Dendritic cell vaccines, 358</p> <p>17.20 Mucosal administration of vaccines, 359</p> <p>17.21 Nasally administered vaccine against genital infections, 360</p> <p>17.22 New strategies for vaccine development, 360</p> <p>17.23 Summary, 362</p> <p><b>Glossary of Terms, 363</b></p> <p><b>Index, 374</b></p>
<p>“Overall, the book is well written, and the concepts are explained clearly, with well-illustrated, informative figures and diagrams.  An 11-page glossary supports that text.  Summing Up: Recommended.  Upper-division undergraduates and above.”  (<i>Choice</i><i>,</i> 1 August 2012)</p> <p> </p>
<p><b>Dr Andrew E. Williams,</b> Imperial College, London, UK.</p>
<b>Immunology Mucosal and Body Surface Defences</b> <p>The vast majority of medically important pathogens infect their host across a body surface such as the skin, or across a mucosal tissue such as the respiratory tract or intestines, as these sites are the ones exposed to the external environment. By focusing on immunity at mucosal and body surfaces this book presents a fresh, new approach to the teaching of immunology.</p> <p>After an introduction to the basic structure of the immune system, the book looks at two important families of signalling molecules: cytokines and chemokines, before covering the workings of the mucosal immune system. It continues by examining immunity against the four major groups of pathogens - viruses, bacteria, fungi and parasites, and concludes by looking at disorders of the immune system, mucosal tumour immunology and the process of vaccination.</p> <ul type="disc"> <li>A fresh, new approach to the subject focusing on mucosal and body surfaces.</li> <li>Describes the mucosal immune systems of the gastrointestinal, respiratory and urogenital tracts, as well as the skin.</li> <li>Details the important roles of cytokines and chemokines in an immune response.</li> <li>Separate chapters devoted to immunity against viruses, bacteria, fungi and parasites.</li> <li>Includes chapter summaries, boxes with topics of special interest and an extensive glossary.</li> <li>Clearly written and well- illustrated in full colour throughout.</li> </ul> <p>Students across a range of disciplines, including biology, biochemistry, biomedicine, medicine and veterinary sciences, will find this book invaluable, both as an introduction to basic immunology and as a guide to mucosal immune defence mechanisms.</p>

Diese Produkte könnten Sie auch interessieren:

Zukunftstechnologie Tissue Engineering
Zukunftstechnologie Tissue Engineering
von: Will W. Minuth, Raimund Strehl, Karl Schumacher
PDF ebook
114,99 €
Biologische Bodensanierung
Biologische Bodensanierung
von: Kassem Alef
PDF ebook
40,99 €
Zukunftstechnologie Tissue Engineering
Zukunftstechnologie Tissue Engineering
von: Will W. Minuth, Raimund Strehl, Karl Schumacher
EPUB ebook
114,99 €